Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PET Imaging of PARP Expression Using 18F-Olaparib
Thomas C. Wilson, Mary‐Ann E. Xavier, James C. Knight, et al.
Journal of Nuclear Medicine (2018) Vol. 60, Iss. 4, pp. 504-510
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 181
Targeted Alpha-Particle Therapy: A Review of Current Trials
Albert Jang, A. Tuba Kendi, Geoffrey B. Johnson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11626-11626
Open Access | Times Cited: 48
Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
Stephen A. Jannetti, Brian M. Zeglis, Michael R. Zalutsky, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 76
PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective
Sridhar Goud Nerella, Priti Singh, Tulja Sanam, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 57
Copper-mediated late-stage radiofluorination: five years of impact on preclinical and clinical PET imaging
Jay S. Wright, Tanpreet Kaur, Sean Preshlock, et al.
Clinical and Translational Imaging (2020) Vol. 8, Iss. 3, pp. 167-206
Open Access | Times Cited: 69
Approaches to PET Imaging of Glioblastoma
Lindsey Drake, Ansel T. Hillmer, Zhengxin Cai
Molecules (2020) Vol. 25, Iss. 3, pp. 568-568
Open Access | Times Cited: 61
PARP Inhibitors in Cancer Diagnosis and Therapy
Chung Ying Chan, Kel Vin Tan, Bart Cornelissen
Clinical Cancer Research (2020) Vol. 27, Iss. 6, pp. 1585-1594
Open Access | Times Cited: 61
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer
Heiko Schöder, Paula Demétrio De Souza França, Reiko Nakajima, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 13, pp. 3110-3116
Open Access | Times Cited: 56
PET imaging of PARP expression using 68Ga-labelled inhibitors
Xiangwei Wang, Wei Liu, Ké Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 9, pp. 2606-2620
Open Access | Times Cited: 21
[123I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
Chung Ying Chan, Zijun Chen, Florian Guibbal, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 12, pp. 1965-1971
Open Access | Times Cited: 17
Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis
Sridhar Goud Nerella, Raman Kumar Joshi, Rose Dawn Bharath, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111979-111979
Closed Access | Times Cited: 46
Manual and automated Cu-mediated radiosynthesis of the PARP inhibitor [18F]olaparib
Florian Guibbal, Patrick G. Isenegger, Thomas C. Wilson, et al.
Nature Protocols (2020) Vol. 15, Iss. 4, pp. 1525-1541
Closed Access | Times Cited: 46
Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies
Hanyi Fang, Xingyi Wang, Xiaoli Lan, et al.
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 16
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
Ramya Ambur Sankaranarayanan, Susanne Kossatz, Wolfgang Weber, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2130-2130
Open Access | Times Cited: 34
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply
Lauren A. McIntosh, Jonathan D. Burns, E. E. Tereshatov, et al.
Nuclear Medicine and Biology (2023) Vol. 126-127, pp. 108387-108387
Open Access | Times Cited: 11
Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging
Chunfeng He, Hui Shi, Boyu Tan, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3840-3853
Closed Access | Times Cited: 4
Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ
Katarína Benčurová, Theresa Balber, Victoria Weissenböck, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
Simplified radiolabeling process toward rapid photoredox-catalyzed aryl 18F-fluorination and PET tracer development
Wei Chen, Yueqi Wang, Lili Pan, et al.
Research Square (Research Square) (2025)
Open Access
Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR
Robert J. Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.
Neuro-Oncology Advances (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 31
Copper-Mediated Radiosynthesis of [18F]Rucaparib
Zijun Chen, Gianluca Destro, Florian Guibbal, et al.
Organic Letters (2021) Vol. 23, Iss. 18, pp. 7290-7294
Open Access | Times Cited: 27
Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications
Renske Altena, Antonios Tzortzakakis, Siri af Burén, et al.
EJNMMI Research (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake
Dong Dai, Yu Jiang, Wenfeng Gou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6726-6737
Closed Access | Times Cited: 3
Targeted radionuclide therapy for gliomas: emerging clinical trial landscape
Michael Weller, Nathalie L. Albert, Norbert Galldiks, et al.
Neuro-Oncology (2024) Vol. 26, Iss. Supplement_9, pp. S208-S214
Open Access | Times Cited: 3
Recent advances in transition metal-mediated/ catalyzed radiofluorination of arenes and heteroarenes for positron emission tomography
Haiyan Chen, Buchuan Zhang, Siyu Chen, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108272-108272
Closed Access
Current Advances in PARP1‐Targeted Theranostics
Jie Tong, Baosheng Chen, Tommaso Volpi, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2025) Vol. 68, Iss. 1-2
Closed Access
Page 1 - Next Page

Scroll to top